经颈静脉肝内门体分流术应用的回顾与展望  

Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China

作　　者：牛猛[1] 孙骏[1] 徐克[1] 钟红珊[1] 

机构地区：[1]中国医科大学附属第一医院介入科,沈阳110001

出　　处：《临床肝胆病杂志》2016年第2期230-233,共4页Journal of Clinical Hepatology

摘　　要：近年来,经颈静脉肝内门体分流术(TIPS)在国内逐步推广并得到广泛认可,此项技术的技术标准、适应证和禁忌证也逐步建立。覆膜支架的诞生成功解决了裸支架分流道闭塞率高的问题,使TIPS迎来了另一个春天。遗憾的是,大多数临床研究发表于覆膜支架前,因此TIPS的临床疗效并不代表本领域的目前状态。随着此项技术的发展,TIPS正不断扩大其适应证,中国作为TIPS大国也急需更多高质量的多中心临床随机对照试验。TIPS在治疗门静脉高压症和肝血管疾病的各种并发症中,取得了越来越多的认可,并必将迎来一个美好的未来。In recent years, transjugular intrahepatic portosystemic shunt （TIPS） has been gradually applied and widely accepted in China, and the technical standards, indications, and contraindications of this technique have also been established gradually. The invention of cov- ered stents successfully solved the issue of a high rate of shunt occlusion seen in bare stents, and thus TIPS is greatly developed. Unfortu- nately, since most clinical studies were published before the invention of covered stents, the clinical effect of TIPS cannot represent the cur- rent status in this field. With the development of this technique, the indications for TIPS are gradually expanded, and as a country with many patients in need of TIPS, high - quality muhicenter randomized controlled clinical trials are urgently needed in China. TIPS has been accept- ed in the treatment of various complications of portal hypertension and hepatic vascular diseases and will enjoy a promising future.

关 键 词：门静脉高压 门体分流术 经颈静脉肝内 食管和胃静脉曲张 

分 类 号：R575.2[医药卫生—消化系统]